The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
25166285 |
17 |
Structure-guided design and optimization of small molecules targeting the protein-protein interaction between the von Hippel-Lindau (VHL) E3 ubiquitin ligase and the hypoxia inducible factor (HIF) alpha subunit with in vitro nanomolar affinities.![EBI](/images/logo_chembl.png) |
University of Dundee |
23977883 |
54 |
Inhibition of hypoxia-inducible factor prolyl hydroxylase domain oxygen sensors: tricking the body into mounting orchestrated survival and repair responses.![EBI](/images/logo_chembl.png) |
Janssen Research and Development |
24436777 |
8 |
Is NMR Fragment Screening Fine-Tuned to Assess Druggability of Protein-Protein Interactions?![EBI](/images/logo_chembl.png) |
University of Cambridge |
32142281 |
24 |
Medicinal Chemistry of Inhibiting RING-Type E3 Ubiquitin Ligases.![EBI](/images/logo_chembl.png) |
Genentech |
30682255 |
14 |
Small-Molecule Modulators of the Hypoxia-Inducible Factor Pathway: Development and Therapeutic Applications.![EBI](/images/logo_chembl.png) |
China Pharmaceutical University |
31035238 |
3 |
Small molecule PROTACs in targeted therapy: An emerging strategy to induce protein degradation.![EBI](/images/logo_chembl.png) |
Shaoxing University |
29144739 |
1 |
Protac-Induced Protein Degradation in Drug Discovery: Breaking the Rules or Just Making New Ones?![EBI](/images/logo_chembl.png) |
Benevolentbio |